American Journal of Drug and Alcohol Abuse

Article	Citations
Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population	57
Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies	51
Assessment of liability to substance use disorder induced by two emerging stimulants, 4,4′-dimethylaminorex and escaline, in mice	38
Differential effects of moderate chronic ethanol consumption on neurobehavior, white matter glial protein expression, and mTOR pathway signaling with adolescent brain maturation	31
A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorder	25
Initial evidence of reliability and validity of an implicit association test assessing attitudes toward individuals who use substances	24
Assessing factors associated with knowledge of Driving Under the Influence (DUI) penalties	22
Willingness to provide a hair sample for drug testing: results from an anonymous multi-city intercept survey	21
Dopamine D2/D3 receptor availability and working memory in stimulant use disorder	20
Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone	19
Opioid overdose after extended-release buprenorphine injection: a case report	19
Alcohol-related non-fatal motor vehicle crash injury in the US from 2019 to 2022	19
Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial	18
In utero chronic cannabis exposure is associated with lower total brain volume in the first month of postnatal life	18
Responding to changes in the unregulated drug supply: the need for a dynamic approach to drug checking technologies	17
Addressing stimulant use disorder through state opioid response grants from the substance abuse and mental health services administration: Missouri’s initial approach	17
Many leveled ordinal models for frequency of alcohol and drug use	17
The alcohol use disorders identification test (AUDIT): factor structure, test-retest reliability and longitudinal measurement invariance across a one-year interval in an Australian sample	16
Association of drinking behaviors with TXNIP DNA methylation levels in leukocytes among the general Japanese population	15
Rapid microinduction of buprenorphine/naloxone for opioid use disorder in a large safety net hospital: a retrospective case series	15
Disentangling the effects of racism-related stress on opioid use disorder and chronic pain outcomes	14
Exploring survey methods for measuring consumption quantities of cannabis flower and concentrate products	14
Internet-based, continuously available Narcotics Anonymous meetings: a new resource for access to Twelve Step support for abstinence	14
Withdrawal interference scale: a novel measure of withdrawal-related life disruption in opioid use disorder and alcohol use disorder	13
A novel rural hospital/clinic-system practice-based research network: the Rural Addiction Implementation Network (RAIN) initiative and its goals, implementation, and early results	13

Assessment of patient perception of treatment assignment and patient-reported outcomes in a cannabis use disorder trial	12
Functional neuroanatomy of craving in heroin use disorder: voxel-based meta-analysis of functional magnetic resonance imaging (fMRI) drug cue reactivity studies	12
Social influence on drug use and sexual behaviors among rural LGBTQ+ individuals	12
Development and initial findings from the Peer Recovery Coach (PRC) checklist: a new tool to assess the nature of peer recovery coaching service delivery	12
Psychometric evaluation of a person-centered opioid and opioid problems perception questionnaire (PC-OOPPQ)	12
Geographic trends in overall and long-acting opioid prescriptions under Medicaid and Medicare Part D in the United States, 2013–2021	12
Plasma concentrations of the inflammatory adipokine lipocalin-2 are not affected by chronic alcohol exposure in rats or acute alcohol administration in people with alcohol use disorder	12
Alterations in surface-based brain morphometry in men with opioid use disorder	11
Alcohol protective behavioral strategies for young adults: a content analysis across drinking contexts and gender	11
The cost-effectiveness of long-term post-treatment peer recovery support services in the United States	11
Changes in attitudes toward alcohol control policies in Lithuania: findings from two representative surveys in 2015 and 2020	10
Anger is more strongly associated with alcohol and tobacco use and use disorders compared to other substances in American adults	10
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use	10
X-ray absorption spectroscopy combined with deep learning for auto and rapid illicit drug detection	10
Cocaine self-administration behavior is associated with subcortical and cortical morphometry measures in individuals with cocaine use disorder	10
Flexibly modeling age trends in the prevalence of co-occurring patterns of substance use and mental health disorders using time-varying effects and latent class analysis	10
Plasma leptin levels are lower in females, but not males, with ketamine use disorder	10
Changes in frequency of cannabis use among people with HIV during the COVID-19 pandemic: a multi-methods study to explore the underlying reasons for change	10
Gene knockdown of HCN2 ion channels in the ventral tegmental area reduces ethanol consumption in alcohol preferring rats	10
Strategies to address co-occurring behavioral health needs among justice-involved youth	9
How much illegally manufactured fentanyl could the U.S. be consuming?	9
Differential prevalence of Adverse Childhood Experiences (ACEs) by gender and substance used in individuals with cannabis, cocaine, opioid, and tobacco use disorders	9
Age patterns and predictors of cannabis initiation among biracial and monoracial U.S. youth	9
Psychometric properties of the Spanish Simultaneous Alcohol and Cannabis Motives Measure (S-SMM) and its short form (S-SMM-SF) among young adults	9
Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorder	9
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study	9
Large-scale longitudinal analysis of the progression of alcohol use among members of a social media platform: an observational study	9
Withdrawal catastrophizing scale: initial psychometric properties and implications for the study of opioid use disorder and hyperkatifeia	9
Coroner county systems are associated with a higher likelihood of unclassified drug overdoses compared to medical examiner county systems	9
Overdoses and deaths related to the use of ketamine and its analogues: a systematic review	9
A study of long-term supraphysiologic-dose anabolic-androgenic steroid use on cognitive function in middle-aged men	8
Processing abnormalities in monetary outcome evaluations among male individuals with opioid use disorder: evidence from feedback-related negativity	8
Cannabis retail store density and county-level mortality from injury in the state of Washington from 2009–2020	8
Assessment of the Short Grit Scale in patients with substance use disorder: Psychometric properties and patient characteristics	8
Six-month length of stay associated with better recovery outcomes among residents of sober living houses	8
Childhood trauma, intraindividual reaction time variability, baseline respiratory sinus arrhythmia, and perceived relapse tendency among males with substance use disorders	7
Exploring prescription opioid misuse among college students: a secondary analysis of ACHA National College Health Assessment data (2019–2022)	7
Alterations in self-reported sensory gating and interoception in individuals frequently using cannabis	7
Effects of fisetin on ethanol-induced rewarding properties in mice	7
Meta-analysis of primary care delivered buprenorphine treatment retention outcomes	7
Telehealth for opioid use disorder: retention as a function of demographics and rurality	6
Fiduciary assignment as a potential intervention for substance use disorder: a retrospective chart review	6
Buprenorphine in safety-sensitive positions	6
Synergistic effect of combined transcranial direct current stimulation and Matrix ‎Model on the reduction of methamphetamine craving and improvement of cognitive ‎functioning: a randomized sham-contro	6
Alcohol use and drinking motives across five countries: a post-COVID-19 pandemic update	6
The global distribution and epidemiology of alcohol and drug use among street-involved children and youth: a meta-analysis	6
Benefits of Alcoholics Anonymous affiliation among meeting attendees in Romania: a mixed methods approach	6
Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids	6
Improving Spanish translations of tobacco dependence measures using cognitive interviewing	6
Opium, phencyclidine, and crack cocaine smoking associations with lung and upper aerodigestive tract cancers: exploratory findings from a case-control study in Los Angeles County	6

Alcohol withdrawal and amphetamine co-use in an animal model for attention deficit hyperactivity disorder	6
A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse	6
Protective effects of naringenin against methamphetamine-induced cell death in dopaminergic SH-SY5Y cells	5
Changes in the proportion of fatal overdoses by substance type in the US, 1999–2021	5
Long-term patient outcomes following buprenorphine/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population	5
Applied statistical methods for identifying features of heart rate that are associated with nicotine vaping	5
Non-prescription pharmacy syringes sales to people who inject drugs (PWID) in Khartoum, Sudan: policy, practice, and perceptions	5
Interpersonal communication and perceived norms as social influence mechanisms of e-cigarette use among adults: a systematic review	5
Hospital adoption of harm reduction and risk education strategies to address substance use disorders	5
Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization	5
Cannabis use among pregnant women under different legalization frameworks in the United States	5
Nonfatal pediatric fentanyl exposures reported to US poison centers, 2015–2023	5
Effects of current smoking severity on brain gray matter volume in opioid use disorder – a voxel-based morphometry study	5
Ethanol causes non-communicable disease through activation of NLRP3 inflammasome: a review on mechanism of action and potential interventions	5
Quantitative and qualitative outcomes associated with inpatient addiction consultation: a scoping review	5
Longitudinal factors associated with increased alcohol consumption in adults during the COVID-19 pandemic	5
Seeing the forest for the trees: a commentary on ‘real-world’ e-cigarette use and readiness to stop smoking among adults who smoke	5
Trends in the availability of comprehensive services within outpatient substance use treatment facilities from 2018 to 2022	4
Leveraging extended-release buprenorphine to improve care for opioid use disorder in the criminal-legal system	4
Harm reduction as treatment for Black and Hispanic individuals: response to Scheidell et al	4
Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder	4
TLR3 activation with poly I:C exacerbates escalated alcohol consumption in dependent male C57BL/6J mice	4
Historical and contextual variation in daily opioid consumption rates: implications for supply control, service delivery, and research	4
Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic	4
Sex and gender differences in co-occurring substance use and depressive disorders: a systematic review	4
Project lifeline: implementing SBIRT in rural pharmacies to address opioid overdoses and substance use disorder	4
Pharmacotherapy and overdose risk following new opioid use disorder diagnosis among Medicaid beneficiaries	4
Evaluation of an online SBIRT training program	4
Comparing substance-involved suicide and unintentional deaths from 2011 to 2021 in Missouri, United States	4
A targeted approach to using e-cigarettes for harm reduction in adults	4
Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis	4
The prevalence of alcohol use and risky driving practises among individuals who consume sedatives nonmedically: findings from the NESARC-III	4
Adolescent stress avoidance influences cue-induced heroin seeking and chaperonin gene expression in the dorsal striatum of adult female rats	4
Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis	4
Psychometric evaluation of two indices assessing stigma toward opioid misuse and treatment among health care providers	4
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature	4
Psychometric properties and invariance testing of the Cannabis Refusal Self-Efficacy Scale in a Chilean sample	4
The association of alcohol consumption with the risk of sarcopenia: a dose-response meta-analysis	4
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C	4
The hidden-zero effect in male individuals with opioid use disorder	4
Treatment of ketamine use disorder with combined gabapentin and topiramate: two case reports	4
Implementing an EMA burst design in community-engaged research: participant and researcher perspectives and recommendations	4
Targeting the Nlrp3 inflammasome as potential treatment for ethanol-induced non-communicable diseases	4
Cannabis use in adolescents and anxiety symptoms and disorders: a systematic review and meta-analysis	4
The role of sleep in the link between cannabis use and memory function: evidence from a cross-sectional study	3
Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection	3
Challenging the 25-year-old ‘mature brain’ mythology: implications for the minimum legal age for non-medical cannabis use	3
Missouri’s Overdose Field Report: descriptive analysis, survival trends, and naloxone dosing patterns from a community-based survey tool, 2018–2022	3
Elbasvir/grazoprevir for the treatment of hepatitis C virus infection in people with opioid use disorder	3
Experiencing violence and other predictors of within-person same-day use of multiple substances in youth: a longitudinal study in emergency settings	3
Flumazenil partially reverses gamma-hydroxybutyrate (GHB)-induced coma: a case report	3
Ancient medicine for a modern disease: traditional Amazonian medicine to treat substance use disorders	3
Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment	3
Simulated opioid choice linked to opioid use disorder severity among veterans with chronic pain: initial validation of a novel paradigm	3
Patient experiences with outpatient opioid use disorder treatment before and during COVID-19: results from a survey of Medicaid members	3
Cigarette and e-cigarette use as a function of psychological distress following COVID-19 related university campus closures	3
Assessing anxiety longitudinally among medical cannabis patients in Pennsylvania	3
Successful treatment of dextromethorphan use disorder with combined naltrexone and gabapentin: a case report	3
Characterization of quality of life among individuals with current treated, untreated, and past alcohol use disorder	3
Alcohol self-administration and nicotine withdrawal alter biomarkers of stress and inflammation and prefrontal cortex changes in Gβ subunits	3
Increased risk of non-fatal overdose associated with broad adverse childhood experiences among people who use drugs in New York City: a latent class analysis	3
Family history, childhood maltreatment, and adolescent binge drinking exert synergistic effects on delay discounting and future alcohol use	3
Possible substance use disorders among first responders during the COVID-19 era: a quasi-experimental study of personal and residential vulnerability	3
Safety and tolerability of progesterone treatment for women with cocaine use disorder: a pilot treatment trial	3
Supporting medication-assisted recovery in recovery residences: staff support, managing built environment threats, and building a supportive network	2
Reasons for use and experiences of using phenibut, a mixed methods analysis of online reports	2
The challenge of unrecorded alcohol consumption in Argentina: estimation and key predictors	2
Exploring the impact of inflammatory cytokines on alcoholic liver disease: a Mendelian randomization study with bioinformatics insights into potential biological mechanisms	2
A systematic meta-epidemiologic review on nonabstinence-inclusive interventions for substance use: inclusion of race/ethnicity and sex assigned at birth/gender	2
Laboratory method to induce state boredom increases impulsive choice in people who use cocaine and controls	2
Practical foundations of machine learning for addiction research. Part I. Methods and techniques	2
Opioid use disorder Cascade of Care: defining a taxonomy for measurement	2
Comparison of the imaging and clinical characteristics between Initial and Recurrent Alcoholic Acute Pancreatitis: a retrospective cross-sectional study	2
Prevalence and correlates of DSM-5 opioid withdrawal syndrome in U.S. adults with non-medical use of prescription opioids: results from a national sample	2
Are you thinking what I’m thinking? Defining what we mean by “polysubstance use.”	2
Opioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention	2
Beneficial effects of atypical antipsychotics on object recognition deficits after adolescent toluene exposure in mice: involvement of 5-HT1A receptors	2
A national longitudinal study of sexual orientation discordance, sexual identity fluidity, and alcohol and other drug use disorder symptoms	2
Adolescent’s explicit and implicit cigarette cognitions predict experimentation with both cigarettes and e-cigarettes	2
Ethnic identity and religiosity are related to lower alcohol use and cannabis use in Arab American college students	2

New therapeutics for the prevention or amelioration of fetal alcohol spectrum disorders: a narrative review of the preclinical literature	2
Alcohol use among adult recent Latino/a immigrants: the role of stress, forced migration, and adherence to traditional gender roles	2
Cannabidiol attenuates methamphetamine-induced conditioned place preference in male rats and viability in PC12 cells through the Sigma1R/AKT/GSK3β/CREB signaling pathway	2
Psychometric properties of the Fletcher Recovery Housing Alliance Measure (FRHAM-12)	2
Safety and efficacy of ketamine for the treatment of patients with alcohol use disorder: a systematic review	2
Sensitivity, specificity and predictive values of ICD-10 substance use codes in a cohort of substance use-related endocarditis patients	2
Changes in alcohol consumption and binge drinking during the COVID-19 pandemic among American Indians residing in California and Oklahoma	2
Understanding readmission to substance use disorder treatment in Chile: a mixed-method study	2
Effectiveness of psychosocial interventions for alcohol use disorder: a systematic review and meta-analysis update	2
Focusing on protective factors, resilience and thriving to reduce health disparities and treatment inequities	2
Psychometric properties and Longitudinal Measurement Invariance of the Spanish version of the Alcohol Expectancies Questionnaire Short Form among young adult binge drinkers	2
Alcohol use severity among Hispanic college students: examining social media discrimination, drinking motives, and resilience in a stress and coping framework	2